Glaukos Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
GKOS New York 3840 www.glaukos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Glaukos Corporation

GKOS Stock Gains Following Positive Study Data on iDose Platform - Jan 15th, 2025 1:51 pm
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform - Jan 14th, 2025 9:05 pm
Here's Why You Should Add Glaukos Stock to Your Portfolio Now - Jan 9th, 2025 12:43 pm
Glaukos Reaches 52-Week High: What's Driving the Stock's Rally? - Jan 7th, 2025 4:45 pm
Glaukos price target raised to $157 from $149 at BTIG - Jan 4th, 2025 12:45 pm
Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA - Dec 24th, 2024 5:38 pm
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™ - Dec 23rd, 2024 12:00 pm
The three-year returns have been stellar for Glaukos (NYSE:GKOS) shareholders despite underlying losses increasing - Dec 21st, 2024 1:36 pm
Glaukos price target raised to $185 from $152 at Truist - Dec 19th, 2024 12:30 pm
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference - Dec 17th, 2024 12:00 pm
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Dec 12th, 2024 7:15 am
5 Medical Device Stocks That Survived the 2024 Market Volatility - Dec 11th, 2024 12:53 pm
Glaukos initiated with a Buy at UBS - Dec 7th, 2024 10:35 am
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - Dec 2nd, 2024 7:29 pm
Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally? - Nov 21st, 2024 1:48 pm
Glaukos Announces Participation in Upcoming Investor Conferences - Nov 8th, 2024 12:00 pm
Glaukos Corporation (NYSE:GKOS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Nov 7th, 2024 11:18 am
Glaukos price target raised to $145 from $135 at Wells Fargo - Nov 6th, 2024 11:30 am
Glaukos Third Quarter 2024 Earnings: Beats Expectations - Nov 6th, 2024 11:02 am
Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nov 5th, 2024 4:30 pm